Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AGS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06767605
What this trial is testing

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Who this might be right for
Hepatitis Autoimmune DiseasePrimary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)+1 more
Asociación Española para el Estudio del Hígado 5,000
Not applicableLooking for participantsNCT07585097
What this trial is testing

Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Who this might be right for
Alagille Syndrome
Ipsen 30
Not applicableLooking for participantsNCT07335523
What this trial is testing

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

Who this might be right for
Exocrine Pancreatic Insuficiency
Digestive Care, Inc. 30
Not applicableLooking for participantsNCT07411716
What this trial is testing

Pediatric Evaluation and Registry for Liver Cholestasis in Canada

Who this might be right for
PFIC - Progressive Familial Intrahepatic CholestasisAlagille Syndrome (ALGS)Cholestasis, Intrahepatic
Children's Hospital of Eastern Ontario 220
Early research (Phase 1)Study completedNCT02963077
What this trial is testing

A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Who this might be right for
Orphan Cholestatic Liver DiseasesPrimary Biliary CirrhosisProgressive Familial Intrahepatic Cholestasis+1 more
Albireo 94
Testing effectiveness (Phase 2)Study completedNCT02160782
What this trial is testing

Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT02363452
What this trial is testing

Reverse Transcriptase Inhibitors in AGS

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
Assistance Publique - Hôpitaux de Paris 11
Large-scale testing (Phase 3)Study completedNCT05543174
What this trial is testing

TAK-625 for the Treatment of Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome (ALGS)
Takeda 7
Not applicableLooking for participantsNCT07293897
What this trial is testing

A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

Who this might be right for
Alagille Syndrome (ALGS)Progressive Familial Intrahepatic Cholestasis (PFIC)
Takeda 50
Testing effectiveness (Phase 2)Study completedNCT02117713
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 34
Not applicableStudy completedNCT02699190
What this trial is testing

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Who this might be right for
LeukodystrophyWhite Matter Disease4H Syndrome+61 more
Children's Hospital of Philadelphia 236
Large-scale testing (Phase 3)Study completedNCT04674761
What this trial is testing

Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Albireo 52
Early research (Phase 1)Study completedNCT03055000
What this trial is testing

Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine

Who this might be right for
Mosquito-Borne Disease
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT01515631
What this trial is testing

Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review

Who this might be right for
Alagille Syndrome
Stanford University 25
Not applicableApproved For MarketingNCT04530994
What this trial is testing

A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05613868
What this trial is testing

TPN-101 in Aicardi-Goutières Syndrome (AGS)

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
Transposon Therapeutics, Inc. 4
Not applicableLooking for participantsNCT06850038
What this trial is testing

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Who this might be right for
Alagille Syndrome
Ipsen 30
Testing effectiveness (Phase 2)Study completedNCT02047318
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 19
Not applicableStudy completedNCT00007033
What this trial is testing

Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease

Who this might be right for
Alagille SyndromeCholestasisBiliary Atresia
National Center for Research Resources (NCRR) 25
Not applicableLooking for participantsNCT06506734
What this trial is testing

Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia

Who this might be right for
Dental Diseases
University Hospital, Toulouse 120
Next Page